000 05254nam a22003735i 4500
001 280075
003 MX-SnUAN
005 20160429154009.0
007 cr nn 008mamaa
008 150903s2008 xxu| o |||| 0|eng d
020 _a9780387725734
_99780387725734
024 7 _a10.1007/9780387725734
_2doi
035 _avtls000332272
039 9 _a201509030221
_bVLOAD
_c201404122104
_dVLOAD
_c201404091835
_dVLOAD
_y201402041025
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aQR180-189.5
100 1 _aGendelman, Howard E.
_eeditor.
_9304761
245 1 0 _aNeuroimmune Pharmacology /
_cedited by Howard E. Gendelman, Tsuneya Ikezu.
264 1 _aBoston, MA :
_bSpringer US,
_c2008.
300 _brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
500 _aSpringer eBooks
505 0 _aImmunology of the Nervous System -- Introducing Neuroimmune Pharmacology -- Innate and Adaptive Immunity in Health and Disease -- Anatomical Networks: Structure and Function of the Nervous System -- The Blood Brain Barrier -- Anterior Chamber and Retina -- Hippocampus and Spatial Memory -- Glial and Neuronal Cellular Compostion, Biology, and Physiology -- Astrocytes, Oligodendrocytes, and Schwann Cells -- Macrophages, Microglia, and Dendritic C -- Neuronal and Glial Signaling -- The Vertebrate Retina -- Lymphocytes and the Nervous System -- Stem Cells -- Neurobiology and Neural Systems -- Cytokines and Chemokines -- CNS Cell Signaling -- Nervous System Diseases and Immunity: Clinical Descriptions -- Neurodegeneration -- Multiple Sclerosis and Other Demyelinating Diseases -- Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, and Axonal Degeneration and Regeneration -- Guillain-Barré Syndrome -- Autoimmune Disease -- NeuroAIDS -- HTLV-I/II -- Viral Encephalitis -- Alzheimer's Disease -- Parkinson's Disease -- Amyotrophic Lateral Sclerosis -- Huntington's Disease -- Prion Diseases -- Glaucoma -- Stroke and Cerebrovascular Disease -- Neurogenesis and Brain Repair -- Familial Neurodegenerative Diseases and Single Nucleotide Polymorphisms -- The Neuroimmune System in Psychiatric Disorders -- Major Depression, Bipolar Syndromes, and Schizophrenia -- Molecular Pathogenesis for Schizophrenia and Major Depression -- Drugs of Abuse and the Immune System -- Therapeutics -- Neuropharmacology -- Neurodegenerative Diseases -- Multiple Sclerosis -- HIV-Associated Dementia -- Immunotherapy -- Alzheimer's Disease -- Parkinson's Disease and Amyotrophic Lateral Sclerosis -- Protective and Regenerative Autoimmunity in CNS Injury -- Adjuvants -- Polymer Nanomaterials -- Gene Therapy and Vaccination -- Proteomics and Genomics -- Neuroimaging.
520 _aThe chapters contained in this volume show scientific relationships among historically separated fields. This allows a unique opportunity for scientists and students to gain broad knowledge in disparate fields of clinical medicine and biomedical research. Overall, the text integrates cutting-edge neuroscience, immunology, pharmacology, neurogenetics, neurogenesis, gene therapy, adjuvant therapy, proteomics, and magnetic resonance imaging. It is a rich harvest and readers will gain a perspective that has not been readily available. Exposure to such a wealth of ideas is bound to inspire readers to undertake new and productive research initiatives. In summary, this is a volume not to be put on the shelf as a reference, but to be read cover to cover by aspiring neuroscientists. Dr. Patrick L. McGeer Professor Emeritus Kinsmen Laboratory of Neurological Research, University of British Columbia This exciting new textbook, Neuroimmune Pharmacology, reflects the history and vision of the Society on NeuroImmune Pharmacology and of the Society’s official publication, the Journal of Neuroimmune Pharmacology. All three represent deliberations arising from a relatively young, interdisciplinary, and dynamic field of research, which have major translational implications for neurodegenerative, neuroinflammatory, neuropsychiatric diseases, and infections of the nervous system. They all demonstrate the synergistic value of integrating the parts: Neuroscience, Immunology, and Pharmacology. The extraordinary accomplishment of Neuroimmune Pharmacology is its comprehensive nature. It will be enthusiastically welcomed by members of the Society and will serve as the definitive resource for all students and researchers interested in various topics that are so well covered in the book. Dr. Phillip K. Peterson President, Society on NeuroImmune Pharmacology Professor, Department of Medicine, University of Minnesota
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700 1 _aIkezu, Tsuneya.
_eeditor.
_9304762
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9780387725727
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-0-387-72573-4
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c280075
_d280075